Kronox Lab Sciences refiles IPO papers with only OFS component, drops fresh issue
Kronox Lab Sciences public issue comprises only an offer-for-sale (OFS) of 96 lakh equity shares by promoters.
Stay updated with breaking news from Kronox Lab Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kronox Lab Sciences public issue comprises only an offer-for-sale (OFS) of 96 lakh equity shares by promoters.
Northern Arc Capital IPO | The IPO comprises a fresh issuance of shares worth Rs 500 crore, and an offer-for-sale of 2.1 crore equity shares by several investors.
Despite general election uncertainty, the primary market remains active with upcoming IPOs like Kronox Lab Sciences and Sattrix Information Security. Analysts foresee a wave of IPOs post-elections, driven by increased domestic capital, improved governance, and supportive government policies.
Kronox has a high purity speciality fine chemicals portfolio with more than 185 products. It has served over 625 customers in the last five financial years.
The firm is likely to mobilise around Rs 150 crore through the offer, which will comprise a fresh issue of shares worth Rs 45 crore and an offer for sale of 78 lakh shares